HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Treatment of postmenopausal breast cancer with bisbromoacetyl hexestrol.

Abstract
Twenty five cases of advanced postmenopausal breast cancer patients were treated with bisbromoacetyl hexestrol 3 CR and 5 PR were achieved. The response rate was 32%, and the average duration of remission 6 months. Vaginal bleeding was seen in 9 cases, 4 of whom were compelled to discontinue treatment.
AuthorsT Zhao, G He
JournalTumori (Tumori) Vol. 74 Issue 6 Pg. 693-5 (Dec 31 1988) ISSN: 0300-8916 [Print] United States
PMID2852862 (Publication Type: Journal Article)
Chemical References
  • Antineoplastic Agents
  • Hexestrol
  • bis(bromoacetyl)hexestrol
Topics
  • Aged
  • Antineoplastic Agents (therapeutic use)
  • Breast Neoplasms (drug therapy)
  • Female
  • Hexestrol (analogs & derivatives, therapeutic use)
  • Humans
  • Menopause
  • Middle Aged

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: